ArbTide

MRNA Funding Rates: Live Across 17 Exchanges

Live

As of 2026-11-18 07:54 UTC, MRNA perpetual funding averages 0.0001% per 8 hours (0.14% APR) across all 17 exchanges that list it, weighted by 24h volume (median 0.0001%). Highest: LBank at 0.0001% per 8h (0.11% APR). Lowest: Toobit at 0.0000% per 8h (0.00% APR). Going long on Toobit and short on LBank collects a gross spread of 0.0001% per 8 hours (0.11% APR) before fees.

MRNA funding rate by exchange

  • 111.58%
    APR
    Market
    MRNA/USD
    Funding rate
    0.0127%
    Interval
    1h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 41.28%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0377%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 12.46%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0114%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 8.55%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0078%
    Interval
    8h
    Next funding
    2026-11-18 07:54 UTC
    Data
    Live

  • 5.26%
    APR
    Market
    MRNA/USDC
    Funding rate
    0.0006%
    Interval
    1h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 4.05%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0037%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 3.50%
    APR
    Market
    MRNA/USDC
    Funding rate
    0.0032%
    Interval
    8h
    Data
    Live

  • 1.37%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0013%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 0.11%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0001%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Next funding
    2026-11-18 08:00 UTC
    Data
    Live

  • 0.00%
    APR
    Market
    MRNA/USDT
    Funding rate
    0.0000%
    Interval
    8h
    Data
    Live

  • -5.58%
    APR
    Market
    MRNA/USDT
    Funding rate
    -0.0051%
    Interval
    8h
    Data
    Live

Showing 17 of 17

MRNA funding arbitrage

LongToobit0.0000%/8hShortLBank0.0001%/8hFunding gap 0.0001% per 8h before fees

Long MRNA on Toobit and short on LBank for a funding gap of 0.0001% per 8 hours. Trading fees, slippage and the price basis between venues reduce the net return; the funding table shows it after fees for your size. See how this gap moved. Learn how funding rate arbitrage works and what a funding rate is.

Frequently asked questions

Is the MRNA funding rate positive right now?
Mostly yes. MRNA funding is positive on 9 of the 17 exchanges, which means longs are paying shorts on those venues.
Which exchange has the highest MRNA funding rate?
LBank at 0.0001% per 8h (0.11% APR). The lowest is Toobit at 0.0000% per 8h (0.00% APR).
What is the MRNA funding arbitrage spread?
The gross spread is 0.0001% per 8 hours (0.11% APR): long MRNA on Toobit and short on LBank. Trading fees, slippage and price basis reduce the net return.
How often is MRNA funding paid?
MRNA funding is paid every 8 hours on KuCoin, OKX, WEEX, Bybit, Lighter, XT.COM, LBank, Binance, Bitget, Gate, HTX, BTSE, Toobit, Aster, and Deepcoin; every hour on Crypto.com and Extended. Rates on this page are also shown as APR so they can be compared directly.